TABLE 1.
Signalment data for horses treated with either injectable or oral omeprazole
| Injectable omeprazole | Oral omeprazole | ||
|---|---|---|---|
| Number of horses | 33 | 12 | |
| Age | 9 (IQR 7–10) | 11 (IQR7‐14) | p = 0.25 |
| Mares ‐geldings‐stallions | 12‐20‐1 | 6‐5‐1 | p = 0.46 |
| Thoroughbred (pure or cross) | 4 (12.1%) | 3 (25%) | p = 0.03 |
| Warmbloods | 11 (33.3%) | 2 (16.7%) | |
| General riding | 16 (458.5%) | 3 (258%) | P = 0.02 |
| Showjumping | 8 (24.221%) | 0 (08%) | P = 0.02 |
| Dressage | 4 (12.1%) | 3 (25%) | |
| Hunting and eventingEventing | 3 (9.133%) | 0 (017%) | |
| RacingOther | 2 (36.1%) | 6 (508%) | |
| Days to approximate 28 day re‐examination | 28 (IQR = 27.25‐28) | 29 (IQR = 24‐33) | p = 0.51 |
| Previous treatment | 9 (27.330%) | 0% |